RBC Capital maintains Coty stock rating on valuation appeal By Investing.com

RBC Capital reiterated an Outperform on Coty with an $8.00 price target, but the stock remains a "show-me" story ahead of fiscal Q3 2026 earnings tomorrow. The firm expects results and Q4 guidance to come in within conservative ranges, while Moody’s kept Coty’s Ba1 rating and turned the outlook negative on weaker operating performance. Other recent actions were mixed-to-negative, including Canaccord’s cut to $2.50 after softer EBITDA versus estimates and BofA’s cut to $1.50 on Middle East-related sales weakness.

Analysis

COTY is in the awkward part of a deleveraging story: the equity can rerate on any hint of cleaner execution, but the hurdle rate is still set by credibility, not valuation. The near-term read-through is that tomorrow’s print is unlikely to be the main catalyst; the market will care far more about whether management can narrow the gap between “cheap on paper” and “self-help that actually shows up” in the next two quarters. That makes the stock hypersensitive to guidance language, mix, and margin bridge assumptions rather than topline alone.

The second-order issue is that a weaker operating backdrop plus a negative ratings bias keeps the cost of capital elevated even if leverage falls mechanically. That matters because beauty brands live on perception and distribution leverage; if retailers sense fragility, they can press for shelf support, promo spend, and inventory discipline, which compresses gross margin and delays the operating inflection. In that setup, the key loser is not just COTY’s equity holders but also any adjacent premium beauty supplier with similar EM/exposure and weaker balance sheet flexibility, since the market will start discounting category-level demand softness rather than company-specific execution.

The contrarian setup is that expectations are already low enough that a merely “less bad” quarter could trigger a sharp squeeze, especially if management frames 2H as stable and reiterates debt reduction. Conversely, the bear case is not a single miss; it is another quarter of conservative guidance combined with no visible improvement in brand momentum, which would validate the credit agencies’ caution and keep the stock trapped in show-me mode for months. The asymmetry is better on the downside if guidance disappoints, because the equity has limited narrative support once the market concludes that leverage is falling but equity value is not being created fast enough.

For a trading lens, this is a volatility event with a likely post-earnings drift rather than a clean one-day directional move. The move higher requires either a clear FY26 margin bridge or evidence that category trends are improving without incremental promo intensity; absent that, rallies should fade into strength. The setup favors tactical, event-driven positioning over outright conviction holdings.

Key Decisions for Investors

• Short COTY into earnings or buy near-dated puts; thesis is that even a decent print will not change the multi-quarter credibility discount, while any guide-down or softer tone can reprice the stock quickly given low absolute expectations.
• If long, use call spreads rather than stock and only on a post-earnings confirmation of stable 2H guidance; upside is meaningful if management surprises on margin/mix, but the trade needs capped premium because the base case remains range-bound.
• Pair trade: long a higher-quality beauty/consumer compounder versus short COTY for 1-3 months; the goal is to isolate execution risk and balance-sheet skepticism rather than take category direction risk.
• For credit-sensitive accounts, avoid adding exposure until management demonstrates two consecutive quarters of operating stability; the negative outlook means equity upside can be capped by financing optics even if EBITDA beats modestly.
• Watch for a post-earnings selloff that pushes COTY back toward distressed-valuation territory; that would be the better entry for a tactical bounce trade, with a stop on any commentary showing real organic margin stabilization.